Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.63), $0.01 worse than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold